Founded in 2019 by Physician couple with training in clinical genomics, supported by global cross functional IT team to apply advanced AI/ML models to translate complex genomic data to simple clinical outputs. Vision of the company is to make Personalized medicine a reality to every individual. We offer DNA/RNA sequencing for our partner institutions and gathered longitudinal phenotypic data along with Whole Exome on 3000 individuals and targeted somatic testing on 300 solid tumors. We developed AI/ML models on this data set to analyze and develop inputs. We believe AI is the way forward in drug discovery and are consistently building capacity to perform big data analytics. We have a process patent on interpretation of Sequenced data.